SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-18-082604
Filing Date
2018-03-14
Accepted
2018-03-14 17:28:33
Documents
2
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d548271d10ka.htm 10-K/A 85747
2 EX-24.1 d548271dex241.htm EX-24.1 9025
  Complete submission text file 0001193125-18-082604.txt   95793
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37587 | Film No.: 18690374
SIC: 2834 Pharmaceutical Preparations